The abstract is read at the publisher; the summary is JClub's.
FKBPL is significantly elevated in hepatocellular carcinoma and is linked to poor prognosis, and its loss suppresses HCC viability and xenograft tumour growth.
- Why it matters: HCC mortality remains high, and resistance to therapy is tied to DNA damage repair; identifying DDRR regulators could reveal new vulnerabilities.
- What they did: Using public dataset analysis and an HCC tissue microarray, the study tested FKBPL function by knockdown or overexpression in HCC cells and measured effects on DDRR, DNA damage, and xenograft growth.
- The result: FKBPL knockdown reduced DNA replication/repair pathways, increased ATM/ATR-dependent DNA damage signalling, and impaired tumour growth; it interacts with RPA1 to stabilize it and support BRCA1 signalling and DNA repair.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.